Max Healthcare Institute Limited has granted 280,308 stock options to eligible employees under its Employee Stock Option Scheme 2022. The grant was approved by the Nomination and Remuneration Committee on November 14, 2025. Each option is convertible into one equity share with a face value of ₹10, and the exercise price is ₹900 per option. The vesting period ranges from one to five years from the grant date.
ESOP Grant Details
Max Healthcare Institute Limited announced the grant of 280,308 stock options to its eligible employees under the Employee Stock Option Scheme 2022 (MHIL ESOP – 2022). The decision was made during a Nomination and Remuneration Committee meeting held on November 14, 2025.
Key Terms of the Options
Each stock option can be converted into one fully paid-up equity share with a face value of ₹10. The exercise price for each option is set at ₹900. The options are subject to pre-vesting conditions and can vest no earlier than one year and no later than five years from the grant date. Once vested, the options can be exercised within three years from the respective vesting date.
ESOP 2022 Administration
The MHIL ESOP – 2022 is administered and implemented by the Nomination and Remuneration Committee. The meeting to approve this grant started at 4:20 pm (IST) and concluded at 4:43 pm (IST) on November 14, 2025.
Source: BSE